Brief: Atara Biotherapeutics Announces $36 Million Registered Direct Offering
03/09/2024 22:24
Sept 3 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* ATARA BIOTHERAPEUTICS ANNOUNCES $36 MILLION REGISTERED
DIRECT
OFFERING
* ATARA BIOTHERAPEUTICS INC - FURTHER STRENGTHENS BALANCE
SHEET
WITH CASH RUNWAY INTO 2027 ENABLING KEY PIPELINE READOUTS
* ATARA BIOTHERAPEUTICS INC - WELL POSITIONED TO EXECUTE ON
TAB-CEL U.S. BLA APPROVAL AND ADVANCEMENT OF ATA3219
Source text for Eikon: ID:nBwwmSMsa
Further company coverage: ATRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing